Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

Clinical trial NCT07539155 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07539155
Sponsor: University of Arkansas
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Borderline Resectable/Unresectable Pancreatic Cancer Non Metastatic Pancreatic Cancer

Start date: 2026-08-01
Primary completion: 2028-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.